RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART) - No Study Results Posted

RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART) (HIV-HAART)

This study is currently recruiting participants.

Study NCT00157027 Information provided by Atlantic Health System

First Received: September 8, 2005 Last Updated: March 29, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	April 2010
Estimated Primary Completion Date:	No date given